abstract |
The present invention provides novel amino acid derivatives having general formula (I), wherein R?1, R2 and R3¿ are as defined herein, or a nontoxic phamaceutically acceptable salt or solvate thereof and are useful in the treatment of disorders which are responsive to the opening of potassium channels. |